SWK Corporation (SWKH)
undefined
undefined%
At close: undefined
16.62
-0.51%
After-hours Dec 13, 2024, 04:00 PM EST

Company Description

SWK Holdings Corporation, a specialty finance company that focuses on the healthcare sector.

It operates in two segments, Finance Receivables and Pharmaceutical Development.

The company provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors.

It also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance.

In addition, the company engages in the pharmaceutical development, formulation and manufacturing, and licensing business through the Peptelligence platform.

Further, it intends to out-license its internal product pipeline to create novel formulations using its proprietary technology to develop treatments for patients and caregivers.

The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009.

SWK Holdings Corporation was founded in 1996 and is headquartered in Dallas, Texas.

SWK Corporation
SWK  Corporation logo
Country United States
IPO Date Sep 23, 1999
Industry Asset Management
Sector Financial Services
Employees 22
CEO Jody. D Staggs

Contact Details

Address:
14755 Preston Road
Dallas, Texas
United States
Website https://www.swkhold.com

Stock Details

Ticker Symbol SWKH
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001089907
CUSIP Number 78501P203
ISIN Number US78501P2039
Employer ID 77-0435679
SIC Code 6159

Key Executives

Name Position
Jody. D Staggs Chief Executive Officer & President
Adam Christopher Rice CPA Chief Financial Officer and Principal Financial & Accounting Officer
Courtney Baker CPA Controller
David R. Earhart General Counsel & Secretary
John David Tamas Director of Underwriting
Kendall Papathanasiou Director of HR

Latest SEC Filings

Date Type Title
Nov 15, 2024 8-K Current Report
Nov 14, 2024 8-K Current Report
Nov 14, 2024 10-Q Quarterly Report
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 01, 2024 3 Filing
Nov 01, 2024 3 Filing
Nov 01, 2024 3 Filing
Nov 01, 2024 3 Filing
Nov 01, 2024 3 Filing
Nov 01, 2024 3 Filing